US Patent Issued to NEXTCURE on Oct. 6 for "Compositions and methods for modulating FLRT3 mediated signal transduction" (Maryland Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,229, issued on Oct. 6, was assigned to NEXTCURE INC. (Beltsville, Md.).

"Compositions and methods for modulating FLRT3 mediated signal transduction" was invented by Dallas Benjamin Flies (Rockville, Md.), Kushal Prajapati (Rockville, Md.), Adem Can Koksal (Gaithersburg, Md.), Linda Liu (Clarksville, Md.) and Solomon Langermann (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods of use thereof for modulating FLRT3 mediated signaling are provided. For example, immunomodulatory agents are provided that reduce FLRT3 expression, ligand binding, crosslinking, FLRT3 mediated signaling, or a combination thereof. In another embo...